Glenmark Pharmaceuticals informs about media release

25 Jan 2024 Evaluate
Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Jiangsu Alphamab Biopharmaceuticals, 3D Medicines (Beijing) and Glenmark announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1465.30 -27.05 (-1.81%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Torrent Pharma 3104.55
Abbott India 27145.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.